Sponsor or institution

Clinical trials and research at Angitia Biopharmaceuticals

• 2Clinical trials
• 9Countries

All recruiting trials (2)

• Dose-finding study of AGA2115 in Chinese adults and adolescents with osteogenesis imperfecta

  This study tests three different dosing regimens of AGA2115 in Chinese adults and adolescents with Osteogenesis Imperfecta to see how safe it is and how well it works.

  Recruiting at 2 sites Phase 2 Angitia Biopharmaceuticals · Beijing, Beijing Municipality and 4 other locations · NCT07557446

• AGA2115 treatment for adults with osteogenesis imperfecta caused by COL1A1 or COL1A2 variants

  This will test whether the drug AGA2115 helps adults (18–75) with Type I, III, or IV osteogenesis imperfecta due to COL1A1 or COL1A2 genetic variants.

  Recruiting at 14 sites Phase 2 Angitia Biopharmaceuticals · Phoenix, Arizona and 25 other locations · NCT07062588

Quick answers

How many clinical trials run by Angitia Biopharmaceuticals are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 9 countries. The most sites are in China (1 trial), Argentina (1 trial), Australia (1 trial), Canada (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →